NasdaqGS - Delayed Quote USD

Atea Pharmaceuticals, Inc. (AVIR)

3.7100 +0.0200 (+0.54%)
At close: 4:00 PM EDT
3.7100 0.00 (0.00%)
After hours: 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
351,367.0000
48,633.0000
Operating Expense
157,488.0000
164,162.0000
130,650.0000
212,990.0000
59,663.0000
Operating Income
-157,488.0000
-164,162.0000
-130,650.0000
138,377.0000
-11,030.0000
Net Non Operating Interest Income Expense
27,057.0000
29,224.0000
11,151.0000
213.0000
83.0000
Pretax Income
-130,431.0000
-134,938.0000
-119,499.0000
138,590.0000
-10,947.0000
Tax Provision
792.0000
1,018.0000
-3,590.0000
17,400.0000
--
Net Income Common Stockholders
-131,223.0000
-135,956.0000
-115,909.0000
121,190.0000
-10,947.0000
Diluted NI Available to Com Stockholders
-131,223.0000
-135,956.0000
-115,909.0000
121,190.0000
-10,947.0000
Basic EPS
-1.63
--
-1.39
1.46
-0.51
Diluted EPS
-1.63
--
-1.39
1.37
-0.51
Basic Average Shares
83,389.7500
--
83,245.3850
82,820.0370
21,592.4410
Diluted Average Shares
83,389.7500
--
83,245.3850
88,249.2430
21,592.4410
Total Operating Income as Reported
-157,488.0000
-164,162.0000
-130,650.0000
138,377.0000
-11,030.0000
Total Expenses
157,488.0000
164,162.0000
130,650.0000
212,990.0000
59,663.0000
Net Income from Continuing & Discontinued Operation
-131,223.0000
-135,956.0000
-115,909.0000
121,190.0000
-10,947.0000
Normalized Income
-131,223.0000
-135,956.0000
-115,909.0000
121,190.0000
-10,947.0000
Interest Income
27,057.0000
29,224.0000
11,151.0000
213.0000
83.0000
Net Interest Income
27,057.0000
29,224.0000
11,151.0000
213.0000
83.0000
EBIT
-157,488.0000
-164,162.0000
-130,650.0000
138,377.0000
-11,030.0000
EBITDA
-157,072.0000
-163,746.0000
-130,390.0000
138,406.0000
-11,011.0000
Reconciled Depreciation
416.0000
416.0000
260.0000
29.0000
19.0000
Net Income from Continuing Operation Net Minority Interest
-131,223.0000
-135,956.0000
-115,909.0000
121,190.0000
-10,947.0000
Normalized EBITDA
-157,072.0000
-163,746.0000
-130,390.0000
138,406.0000
-11,011.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
0.0001
--
12/31/2020 - 10/30/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RPHM Reneo Pharmaceuticals, Inc.
1.6700
+1.21%
 
NXTC NextCure, Inc.
1.3500
+4.65%
 
TIL Instil Bio, Inc.
10.60
+2.02%
 
CTMX CytomX Therapeutics, Inc.
1.5900
-0.62%
 
ACHL Achilles Therapeutics plc
0.7600
-2.69%
 
SYBX Synlogic, Inc.
1.8700
-1.06%
 
ALGS Aligos Therapeutics, Inc.
0.7820
-4.40%
 
GLPG.AS Galapagos NV
26.68
+0.45%
 
SPRB Spruce Biosciences, Inc.
0.7000
-0.14%
 
SPRO Spero Therapeutics, Inc.
1.4600
+2.10%